Founders Financial Alliance, LLC Bristol Myers Squibb CO Transaction History

Founders Financial Alliance, LLC

$356 Million
Q4 2024

A detailed history of Founders Financial Alliance, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Founders Financial Alliance, LLC holds 8,381 shares of BMY stock, worth $506,380. This represents 0.13% of its overall portfolio holdings.

Number of Shares

8,381

Previous 8,417 0.43%

Holding current value

$506,380

Previous $435,000 8.97%

% of portfolio

0.13%

Previous 0.12%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$51.92 - $59.94 $1,869 - $2,157	-36 Reduced 0.43%	8,381 $474,000
Q3 2024 Nov 01, 2024	BUY	$39.66 - $51.75 $1,070 - $1,397	27 Added 0.32%	8,417 $435,000
Q2 2024 Aug 23, 2024	BUY	$40.25 - $52.99 $51,801 - $68,198	1,287 Added 18.12%	8,390 $348,000
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $13,194 - $14,960	275 Added 4.03%	7,103 $385,000
Q4 2023 Feb 09, 2024	BUY	$48.48 - $57.85 $5,138 - $6,132	106 Added 1.58%	6,828 $350,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $45,327 - $50,683	-783 Reduced 10.43%	6,722 $390,000
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $36,760 - $40,816	577 Added 8.33%	7,505 $479,000
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $28,846 - $32,718	-439 Reduced 5.96%	6,928 $480,000
Q4 2022 Feb 15, 2023	BUY	$68.48 - $81.09 $21,913 - $25,948	320 Added 4.54%	7,367 $529,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $110 - $65,237	849 Added 13.7%	7,047 $501,000
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $71,893 - $79,180	-990 Reduced 13.77%	6,198 $477,000
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $35,043 - $42,020	-570 Reduced 7.35%	7,188 $525,000
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $30,783 - $35,886	574 Added 7.99%	7,758 $484,000
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $6,508 - $7,624	110 Added 1.55%	7,184 $424,000
Q2 2021 Aug 02, 2021	BUY	$61.91 - $67.42 $13,310 - $14,495	215 Added 3.13%	7,074 $473,000
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $92,807 - $104,381	1,564 Added 29.54%	6,859 $443,000
Q4 2020 Feb 04, 2021	BUY	$57.74 - $65.43 $46,249 - $52,409	801 Added 17.82%	5,295 $327,000
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $258,090 - $285,998	4,494 New	4,494 $272,000

Others Institutions Holding BMY

# of Institutions

2,764

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $128B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Financial Alliance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Founders Financial Alliance, LLC with notifications on news.

Account

Founders Financial Alliance, LLC Bristol Myers Squibb CO Transaction History